Halozyme Therapeutics shares owned by Argent Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Argent Capital Management
from 13F filings
Historical chart of Argent Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Argent Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Argent Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $466k | 6.4k | 73.34 |
| 2025-06-30 | $661k | 13k | 52.02 |
| 2025-03-31 | $772k | 12k | 63.81 |
| 2024-12-31 | $614k | 13k | 47.81 |
| 2024-09-30 | $544k | 9.5k | 57.24 |
| 2024-06-30 | $437k | 8.3k | 52.36 |
| 2022-03-31 | $246k | 6.2k | 39.87 |
| 2021-12-31 | $252k | 6.3k | 40.19 |
| 2021-09-30 | $254k | 6.2k | 40.74 |
| 2021-06-30 | $285k | 6.3k | 45.35 |
| 2021-03-31 | $340k | 8.2k | 41.72 |
| 2020-12-31 | $374k | 8.8k | 42.69 |
| 2020-09-30 | $610k | 23k | 26.27 |